Evidence map›Paper›PMID 18214718›Full record

ReviewThe American journal on addictions

Neurobiological processes in adolescent addictive disorders.

Ty S Schepis, Bryon Adinoff, Uma Rao

Abstract readReview
In one paragraph

Review in The American journal on addictions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Substance abuse and suicide risk among adolescents.European archives of psychiatry and clinical neuroscience · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ty S SchepisDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Bryon Adinoff
Uma Rao

Funding

Research Training Fellowship in Substance use and Addiction (RTFSA)T32DA007238 · NIDA · YALE UNIVERSITY · PI BRIAN D. KILUK, ISMENE L. PETRAKIS · 1988 to 2026
$5.7M
Risk for Substance Abuse in Depressed AdolescentsR01MH062464 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2001 to 2006
$2.4M
Stress Response and Smoking Cessation in Depressed YouthR01DA015131 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2003 to 2007
$2.4M
Markers of Risk for Nicotine Dependence in YoungstersR01DA014037 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2001 to 2006
$1.9M
Treatment Prediction in Adolescent and Adult DepressionR01MH068391 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2004 to 2012
$1.7M
Stress and Risk for Substance Abuse in AdolescentsR01DA017804 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2004 to 2008
$1.6M
Impulsivity, Neural Deficits, and Cocaine RelapseR01DA023203 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI ADINOFF, BRYON H. · 2007 to 2011
$1.5M
LIMBIC SENSITIVITY IN COCAINE ADDICTIONR01DA011434 · NIDA · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI ADINOFF, BRYON H · 1998 to 2005
$1.5M
Neuronal Risk Markers for Nicotine Dependence in YouthR01DA017805 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI RAO, UMA · 2004 to 2010
$1.4M
NIDA NIH HHS DA 007238NIDA NIH HHS DA 11434NIDA NIH HHS DA 15131NIDA NIH HHS DA 17804NIDA NIH HHS DA 17805NIDA NIH HHS R01 DA011434NIDA NIH HHS R01 DA014037NIDA NIH HHS R01 DA015131NIDA NIH HHS R01 DA017804NIDA NIH HHS R01 DA017805NIDA NIH HHS R01 DA023203NIDA NIH HHS T32 DA007238NIMH NIH HHS MH 62464NIMH NIH HHS MH 68391NIMH NIH HHS R01 MH062464NIMH NIH HHS R01 MH068391
6 · The paper itself

Abstract

The purpose of this review is to summarize the neurobiological factors involved in the etiology of adolescent addiction and present evidence implicating various mechanisms in its development. Adolescents are at heightened risk for experimentation with substances, and early experimentation is associated with higher rates of SUD in adulthood. Both normative (e.g., immature frontal-limbic connections, immature frontal lobe development) and non-normative (e.g., lowered serotonergic function, abnormal hypothalamic-pituitary-adrenal axis function) neurobiological developmental factors can predispose adolescents to a heightened risk for SUD. In addition, a normative imbalance in the adolescent neurobiological motivational system may be caused by the relative underdevelopment of suppressive mechanisms when compared to stimulatory systems. These neurobiological liabilities may correspond to neurobehavioral impairments in decision-making, affiliation with deviant peers and externalizing behavior; these and other cognitive and behavioral traits converge with neurobiological factors to increase SUD risk. The progression to SUD acts as an amplifying feedback loop, where the development of SUD results in reciprocal impairments in neurobehavioral and neurobiological processes. A clearer understanding of adolescent neurobiology is a necessary step in the development of prevention and treatment interventions for adolescent SUD.

Indexed as

AdolescentBehavior, AddictiveDecision MakingFrontal Lobegamma-Aminobutyric AcidHumansHypothalamo-Hypophyseal SystemHypothalamusNerve Fibers, MyelinatedPeer GroupPituitary-Adrenal SystemPrefrontal CortexReceptors, CannabinoidReceptors, N-Methyl-D-AspartateSerotoninSubstance-Related Disordersgamma-Aminobutyric AcidReceptors, CannabinoidReceptors, N-Methyl-D-AspartateSerotonin

Identifiers

PMID18214718
PMCPMC2274940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.